Searched for
BAYER CORPORATION
Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...- 500 LPM capacity Oxygen plant set up at the GMCH Guwahati's Cardiothoracic & Neuroscience CentreBayer has set up the oxygen plant at the CN Centre of the Gauhati Medical College and Hospital (GMCH), in partnership with LabourNet as par...
- Bayer’s move to block Natco’s colorectal cancer brand dismissed by Delhi HCBayer raised the objection against Natco’s brand launched under the name Regonat alleging infringement of its patent rights.
- Bayer Wins US Approval Russian Journalist to Buy MonsantoThe agreement requires the sale of assets to BASF SE that Bayer has previously announced. The divestiture package is worth about $9 billion...
- Vijay Mallya on three-month watch at Bayer CropScienceVijay Mallya assured the board that he would settle dues with the banks and denied allegations of money laundering.
- Bayer to rename MaterialScience business as CovestroGerman conglomerate Bayer today announced the renaming of its MaterialScience business as Covestro.
- Bayer to focus on life science business, spin off polymer divisionThe aim would be to continue the positive development of these activities in the future through further investment in growth, the statement...
- India lawyers bag Antitrust Writing AwardTwo young Indian lawyers today bagged the prestigious Antitrust Writing Award for their article on "compulsary licensing in India".
- Intellectual board upholds CL to Natco for cancer drugThe IPAB has upheld the compulsory licence issued to Natco Pharma for production and marketing of generic version of cancer drug Nexavar.
- Bayer set to sell off Powai HQ for over Rs 90 croreLocated a stone’s throw from the Colgate headquarters, the six-storey building’s sale, to be finalized soon, is estimated to fetch Bayer ov...
- Bayer says it will defend its intellectual property rights on cancer drugBayer today said it will continue to defend its IP rights while expressing disappointment at the IPAB decision to reject the firm's plea to...
- Pharma Department proposes negotiating patent drug rates with firmsThe department is the convener of an inter-ministerial group comprising DIPP and the Health Ministry to modulate a pricing mechanism for pa...
- US accuses India of WTO rules violation over Nexavar: ReportThe government had defended the move, with Commerce and Industry Minister Anand Sharma stating that India did not violate any WTO norms.
- No applications pending from pharmaceutical companies seeking compulsory licenses: GovernmentThe government has clarified that no applications are pending from pharmaceutical companies seeking compulsory licences for producing low-c...
- Patented drugs: No application pending for compulsory license, says governmentAmid concerns that more domestic pharma companies could seek compulsory licenses to replicate patented drugs, the government said no such a...
- Bayer challenges Nexavar generic licence orderBayer has filed an appeal against a patents order, which allowed domestic drug maker Natco Pharma to sell a generic version of the German f...
- Cipla shares up over 2 per cent on boursesCipla today notched up 2.46 per cent gain on BSE after the company slashed the prices of its generic drugs, used in treating cancers of bra...
- Major win for Indian pharma cos as HC dismisses Bayer petitionThe Delhi High Court (HC) on Tuesday dismissed German drug major Bayer Healthcare’s attempt to stop Drug Controller General of India (DCGI)...
- EU slaps fines on 5 chemical giantsEuropean Union regulators slapped five companies, including DuPont and Dow Chemical, with $358 million in fines on Wednesday for fixing the...
- Biocon signs agreement with BayerBiotech major Biocon Limited announced on Wednesday a licensing agreement with multinational healthcare corporation Bayer HealthCare (BHC) ...
Load More
